NHS England commissions study on effects of puberty blockers The ‘Pathways trial’ will assess the impact of GnRH analogues for puberty suppression in more than 200 children and young people aged under 16 years.…
Cancer therapies made from recycled nuclear fuel to be backed by government funding Researchers from one of the projects will use the radionuclide lead-212 to create treatments called ‘target alpha therapies’ that could destroy cancer cells with minimal damage to healthy tissue.…
People with eczema can bathe as often as they want, government-funded study finds Researchers found that the frequency in which participants washed had no correlation with increased skin dryness.…
Oral insulin found to delay onset of type 1 diabetes in children Researchers found that the progression to type 1 diabetes mellitus was around 50% slower in infants genetically at risk of the disease who received oral insulin for three years compared to the placebo group.…
Focus on early stages of supply chain to address medicines shortages, study finds Researchers said that other contributing factors to global supply issues were poor forecasting based on “outdated” prescription data and procurement policies.…
Promoting public trust in pharmaceutical health systems is ‘critical’ The Journal of Pharmaceutical Health Services Research’s new themed collection highlights the latest research on improving transparency and accountability in pharmaceutical and health systems.…
‘Cocktail’ of medicines in waterways could pose new AMR threat Research has revealed that medicines combined with ciprofloxacin are more likely to increase antibiotic-resistant genes compared with exposure to antibiotics alone.…
Health news round-up: clinical research and interdisciplinary working Senior clinical reporter Joanna Robertson summarises some important developments in health news.…
RPS appoints new chief scientist Amira Guirguis, who chairs the RPS science and research committee, will begin her role on a phased basis from 13 October 2025.…
Time to approve UK clinical trials has more than halved, says MHRA The Medicines and Healthcare products Regulatory Agency said the introduction of AI methods had contributed to quicker approval times.…
